Bookmark

Add to MyYahoo RSS

Hematology News

News on Hematology continually updated from thousands of sources around the net.

17 min ago | Burnley Citizen

BATTLER: Brave East Lancs boy helping others to face cancer

Rieli Biggins, nine, underwent three years of chemotherapy to help overcome the acute lymphoblastic leukaemia he was diagnosed with at the age of three.

Comment?

Related Topix: Medicine, Cancer, Health, Oncology

Wed Jul 09, 2014

BioMed Central

BiOsimilaRs in the management of anaemia secondary to chemotherapy in ...

The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies.

Comment?

Related Topix: Marketing, Oncology, Medicine, Lymphoma, Health

CiteULike

Targeted therapeutics in treatment of children and young adults with...

Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature.

Comment?

Related Topix: Oncology, Medicine

CBS News

Program to help "forgotten" teen cancer patients

Better treatments and screenings are helping children and older adults with cancer live longer.

Comment?

Related Topix: Cancer, Medicine, Health, Oncology

Los Angeles Times

Keck Medicine pushing into O.C. with oncology network acquisition

Keck Medicine of USC has acquired an oncology business as part of an expansion into Orange County.

Comment?

Related Topix: Oncology, Medicine, Orange County, CA, Newport Beach, CA

Medical News Today

New test predicts survival and disease progression in blood cancer patients

Researchers from Cardiff University's School of Medicine used pioneering techniques for measuring the length and function of tiny structures known as 'telomeres' - repeating sections of DNA found at the ends of chromosomes.

Comment?

Related Topix: Lymphoma, Health, Medicine, Leukemia

Tue Jul 08, 2014

P&T Community

Personalized Cell Therapy CTL019 Receives FDA - Breakthrough Therapy' Designation

The FDA has granted "breakthrough therapy" status to CTL019 , an investigational chimeric antigen receptor therapy for the treatment of pediatric and adult patients with relapsed or refractory acute lymphoblastic leukemia .

Comment?

Related Topix: Food and Drug Administration, Leukemia, Health, Medicine

Naperville Sun

Health Aware: Aurora woman takes action against high cancer risk

Based on her own extensive experience being treated for and attempting to prevent cancer, Sheila Tucker strongly urges people to learn their family history, make time to see their doctor, stay on schedule with mammograms and other screenings, and take advantage of genetic testing.

Comment?

Related Topix: Medicine, Genetics, Naperville, IL, Health, Breast Cancer, Oncology

BioSpace

Boehringer Ingelheim Corporation's Volasertib Phase 2 Data Including...

Volasertib has not been approved by the FDA; its safety and efficacy have not been established.

Comment?

Related Topix: Medicine, Leukemia, Health, Healthcare Law, Law, Food and Drug Administration, Oncology

The Daily Record

New cancer fighting jag could help thousands of Scottish patients gain better quality of life

THOUSANDS of Scots cancer patients could have a better quality of life after a radical A treatment was approved yesterday.

Comment?

Related Topix: Lymphoma, Health, Medicine

Mon Jul 07, 2014

BioSpace

FDA Approves Novo Nordisk A/S's NovoSeven?? RT To Treat Glanzmann's...

Glanzmann's Thrombasthenia is a rare genetic bleeding disorder with limited treatment options.

Comment?

Related Topix: Food and Drug Administration, Genetics, Medicine, Hemophilia, Health

BioSpace

FDA Grants Spectrum Pharmaceuticals, Inc. Accelerated Approval Of...

Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration has granted Accelerated Approval of Beleodaqa for the treatment of patients with relapsed or refractory peripheral T-cell ... (more)

Comment?

Related Topix: Biotech, Healthcare Law, Food and Drug Administration, Medicine, Law, Spectrum Pharmaceuticals, Healthcare Industry, Oncology

The Summerville Journal-Scene

Robert Silgals, MD

Dr. Robert Silgals has cared for Lowcountry patients who have cancer and blood disorders for almost 29 years.

Comment?

Related Topix: Medicine, Health, Breast Cancer, Oncology

Medical News Today

FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma

The U.S. Food and Drug Administration has approved Beleodaq for the treatment of patients with peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .

Comment?

Related Topix: Food and Drug Administration, Lymphoma, Health, Medicine, Oncology, Leukemia

Sun Jul 06, 2014

Hispanic Business

IVD Market 2018: Increased Adoption of POC Diagnostic Tests is a Key...

IVD Market 2018: Increased Adoption of POC Diagnostic Tests is a Key Trend, Says New Research Report at Sandlerresearch.org In the recent past, there has been an increased adoption of POC diagnostic tests by patients.

Comment?

Related Topix: Infectious Diseases, Medicine

Sat Jul 05, 2014

Scoop

Innovation partnership to unlock the potential of e-health

Patients in the Waitemata district will ultimately benefit from improved health outcomes under an agreement to develop new e-health initiatives between Waitemata DHB and New Zealand-owned global health software company Orion Health.

Comment?

Related Topix: Medicine

Fri Jul 04, 2014

Examiner.com

FDA accelerates approval of Beladoaq to treat peripheral T-cell lymphoma

Beleodaq just received FDA approval for the for the treatment peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .

Comment?

Related Topix: Food and Drug Administration, Lymphoma, Health, Medicine, Oncology

Thu Jul 03, 2014

BioSpace

FDA Green Lights Spectrum Pharmaceuticals, Inc.'s Beleodag To Treat Rare Form Of Lymphoma

FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma The U.S. Food and Drug Administration today approved Beleodaq for the treatment of patients with peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .

Comment?

Related Topix: Food and Drug Administration, Lymphoma, Health, Biotech, Medicine, Spectrum Pharmaceuticals, Healthcare Industry, Oncology

Malaysian National News Agency

Vietnam Launches Cross-Country Blood Donation Campaign

A cross-country blood donation campaign was launched in Rach Gia city in southern province of Kien Giang on Thursday, Vietnam News Agency reported.

Comment?

Related Topix: Southeast Asia, World News, Vietnam, Medicine, Thailand

Wed Jul 02, 2014

Business Wire

Research and Markets: Impact of US Healthcare Reform on the In Vitro Diagnostics Market 2014

This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics market, diagnostic test service providers, and IVD manufacturers.

Comment?

Related Topix: Medicine

•••
•••
•••
•••
•••
•••
•••